News and Events

April 26, 2023
Dr. Matthew Greenblatt, an associate professor of pathology and laboratory medicine at Weill Cornell Medicine, has been awarded the Pershing Square Foundation’s Maximizing Innovation in Neuroscience Discovery (MIND) Prize to support his work studying how bone cells may influence Alzheimer’s disease progression.
April 25, 2023
Read the latest  WCM Pathology Newsletter to learn more about our Research Highlights, Scholarly Advances, new faculty and much more. You can also read our past issues here.
April 16, 2023
Strokes cause numerous changes in gene activity in affected small blood vessels in the brain, and these changes are potentially targetable with existing or future drugs to mitigate brain injury or improve stroke recovery, according to a study led by Weill Cornell Medicine scientists.
March 21, 2023
Congratulations to Drs. Amy Chadburn and Cynthia Magro on being recipients of the Exceptional Women in Medicine by Castle Connolly 2023!
February 24, 2023
Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute, part of the National Institutes of Health, to investigate the molecular mechanisms by which immune cells called B cells interact with Epstein-Barr virus (EBV) to cause lymphoma, particularly in people living with HIV. The funding will support projects that began with a grant awarded by the 
February 8, 2023
Five teams led by Weill Cornell Medicine scientists have been awarded funding from the Starr Cancer Consortium in its 16th annual grant competition. The grants will fund research on the molecular origins and evolution of blood, bladder, breast, and colon cancers.
January 31, 2023
Please join us in congratulating our Chair Dr. Massimo Loda on today earning a 2022 Prostate Cancer Foundation Challenge Award for his project, "Targeting Lipid Metabolism and Diet in Patients with Locally Advanced Prostate Cancer."
December 17, 2022
Individuals who were already pregnant at the beginning of the COVID-19 pandemic had a 50 percent lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the general population, according to a new model created by Weill Cornell Medicine, NewYork-Presbyterian and University of Oxford investigators.
December 15, 2022
An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators. Mesenchymal colorectal cancer (mCRC) accounts for about one-third of all colorectal cancers. Targeted immune therapies aren't effective against this form of cancer because the environment inside the tumor keeps immune cells that would kill the tumor cells at bay. But a team led by Dr. Maria Diaz-Meco and Dr. Jorge Moscat, who are both Homer T. Hirst III Professors of Oncology in Pathology at Weill...
December 13, 2022
The long-term immune response to SARS-CoV-2 mRNA vaccination was similar in pregnant individuals compared with non-pregnant individuals of reproductive age, according to a study by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The similarity in protection is noteworthy, given that pregnancy alters the immune system, and potentially the response to vaccination.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700